Roehrborn CG - Search Results

1

Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy.

Karam JA, Lotan Y, Karakiewicz PI, Ashfaq R, Sagalowsky AI, Roehrborn CG, Shariat SF. Karam JA, et al. Among authors: roehrborn cg. Lancet Oncol. 2007 Feb;8(2):128-36. doi: 10.1016/S1470-2045(07)70002-5. Lancet Oncol. 2007. PMID: 17267327

2

Long-term patient survival after cystectomy for regional metastatic transitional cell carcinoma of the bladder.

Roehrborn CG, Sagalowsky AI, Peters PC. Roehrborn CG, et al. J Urol. 1991 Jul;146(1):36-9. doi: 10.1016/s0022-5347(17)37708-x. J Urol. 1991. PMID: 2056601

3

Functional characteristics of the Camey ileal bladder.

Roehrborn CG, Teigland CM, Sagalowsky AI. Roehrborn CG, et al. J Urol. 1987 Oct;138(4):739-42. doi: 10.1016/s0022-5347(17)43357-x. J Urol. 1987. PMID: 3656523

4

Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology.

Roehrborn CG, Gregory A, McConnell JD, Sagalowsky AI, Wians FH Jr. Roehrborn CG, et al. Urology. 1996 Dec;48(6A Suppl):23-32. doi: 10.1016/s0090-4295(96)00606-1. Urology. 1996. PMID: 8973696 Clinical Trial.

5

Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy.

Hall MC, Womack JS, Roehrborn CG, Carmody T, Sagalowsky AI. Hall MC, et al. Among authors: roehrborn cg. J Urol. 1998 Sep;160(3 Pt 1):703-6. doi: 10.1016/S0022-5347(01)62763-0. J Urol. 1998. PMID: 9720526

6

Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Hall MC, et al. Among authors: roehrborn cg. Urology. 1998 Oct;52(4):594-601. doi: 10.1016/s0090-4295(98)00295-7. Urology. 1998. PMID: 9763077

7

Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial.

Djavan B, Shariat S, Fakhari M, Ghawidel K, Seitz C, Partin AW, Roehrborn CG, Marberger M. Djavan B, et al. Among authors: roehrborn cg. Urology. 1999 Feb;53(2):251-9. doi: 10.1016/s0090-4295(98)00538-x. Urology. 1999. PMID: 9933035 Clinical Trial.

8

Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia.

Djavan B, Roehrborn CG, Shariat S, Ghawidel K, Marberger M. Djavan B, et al. Among authors: roehrborn cg. J Urol. 1999 Jan;161(1):139-43. J Urol. 1999. PMID: 10037386 Clinical Trial.

9

Prospective determination of the hormonal response after cessation of luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer.

Hall MC, Fritzsch RJ, Sagalowsky AI, Ahrens A, Petty B, Roehrborn CG. Hall MC, et al. Among authors: roehrborn cg. Urology. 1999 May;53(5):898-902; discussion 902-3. doi: 10.1016/s0090-4295(99)00061-8. Urology. 1999. PMID: 10223480 Clinical Trial.

10

Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach.

Lotan Y, Roehrborn CG. Lotan Y, et al. Among authors: roehrborn cg. J Urol. 2002 Jan;167(1):75-9. J Urol. 2002. PMID: 11743279

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

532 results

Search Page

Filters